NDC 68788-8822-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8822
- Requested NDC
- 68788-8822-01
- Package NDCs from labels
- 68788-8822-2, 68788-8822-3, 68788-8822-4, 68788-8822-6, 68788-8822-9, 68788-8822-1, 68788-8822-8, 68788-8822-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2025-02-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol Tablets USP Rx Only | Preferred Pharmaceuticals Inc. | 2025-02-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8822-1 | Methocarbamol | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 68788-8822-2 | Methocarbamol | 20 in 1 BOTTLE | TABLET | 20 | 1 | |
| 68788-8822-3 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 68788-8822-4 | Methocarbamol | 40 in 1 BOTTLE | TABLET | 40 | 1 | |
| 68788-8822-6 | Methocarbamol | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 68788-8822-8 | Methocarbamol | 120 in 1 BOTTLE | TABLET | 120 | 1 | |
| 68788-8822-9 | Methocarbamol | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8822 | METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 7 package rows | 20250212_eed9ebd1-c243-4e82-bf4e-5fec370e722e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8822-1 | EA - Each | 68788-8822 | 12fdaf63-6d7e-4bd1-ba7d-a0eb6a0d0ca1 | 1 | 2025-03-04 |
| 68788-8822-2 | EA - Each | 68788-8822 | faf64768-ef31-4c2c-8593-a45c161c1c8e | 1 | 2025-03-04 |
| 68788-8822-3 | EA - Each | 68788-8822 | 504ab78c-eadb-4c7f-b301-908050639502 | 1 | 2025-03-04 |
| 68788-8822-4 | EA - Each | 68788-8822 | 6a80ba02-fbd5-4c11-93b2-6dabd24e578f | 1 | 2025-03-04 |
| 68788-8822-6 | EA - Each | 68788-8822 | 9396f5eb-8a9d-4635-bb76-820a8224acc6 | 1 | 2025-03-04 |
| 68788-8822-8 | EA - Each | 68788-8822 | 818da428-21c7-4e2f-afe3-599290bb036f | 1 | 2025-03-04 |
| 68788-8822-9 | EA - Each | 68788-8822 | 04b32e89-33bb-4641-a211-756c87b933ac | 1 | 2025-03-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2026-11-06 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Doc Rx | 5e55526f-bb34-4b67-85ea-b2765e8066bb | 2026-11-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-11-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2026-11-04 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6ca768bf-5095-4148-82d2-a0c2dec16d87 | 2026-11-03 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | American Health Packaging | 1b5afc6c-e09c-41bd-8b7e-d12051b33a4b | 2026-10-29 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d8e3f8dc-9751-419b-8601-d85c43415c82 | 2026-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 2026-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | REGIMED MEDICAL | d4433a71-5cf9-4a32-8902-1c522f1a9acd | 2026-10-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules India Ltd | 42c0a177-7d62-4bcf-9fce-7dd484cda4d5 | 2026-10-07 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | Henry Schein, Inc | d48d76af-b55a-4908-95ff-e7de615c0513 | 2026-10-05 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | ASCLEMED USA INC. | 077fa923-bee0-4b34-a52d-6f870bcb4828 | 2026-09-29 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | 7dafab15-db4c-4425-b1a2-e56433ecccf6 | 2026-09-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | d0acdf52-e1a9-4489-91e1-ef434d311613 | 2026-09-23 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | e5fe4627-11cb-4ebd-8eb0-9be807446fdf | 2026-09-23 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | St. Mary's Medical Park Pharmacy | 5bc70fe6-67a6-795b-e063-6394a90a1193 | 2026-09-17 | Warnings, Adverse reactions | 197943 125OD7737X |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 5b9b48e2-4ff4-3ceb-e063-6394a90a0499 | 2026-09-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 3e4c88fe-bc3d-463f-973c-e52062e4d4ba | 2026-09-14 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | REMEDYREPACK INC. | 87ff444e-d502-428c-8be7-89d36c0cf709 | 2026-09-11 | Warnings, Adverse reactions | 197944 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.